Skip to content

Study of Hair Health Gummies in People with Telogen Effluvium Hair Loss

An Open-Labeled Single Arm study to assess efficacy of hair health gummies in patients with Telogen Effluvium - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/112992
Enrollment
100
Registered
2026-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hair Health Gummies supplements: Take Hair Health Gummies once daily after a meal for a period of 90 days Control Intervention1: NIL: NA

Sponsors

Wedjat Health Solutions Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of both sexes aged 18-50 years, inclusive. 2. Patients diagnosed with Telogen Effluvium based on past medical history. 3. Availability of the signed and dated Informed Consent Form of the Patient Information Sheet.

Exclusion criteria

Exclusion criteria: 1. Patients currently undergoing other treatments for hair loss. 2. Patients with other forms of alopecia. 3. Age below 18 years. 4. Patients not willing to participate. 5. Other conditions which, in the opinion of the physician-investigator, prevent the patient from being included in the study.

Design outcomes

Primary

MeasureTime frame
Increase in hair density.Timepoint: Visit 1 and Visit 4

Secondary

MeasureTime frame
Reduction in hair shedding.Timepoint: Visit 2, Visit 3, Visit 4;Improvement in hair texture and quality.Timepoint: Visit 2, Visit 3, Visit 4;Patient satisfaction.Timepoint: Visit 2, Visit 4;Quality of life assessed through a questionnaire.Timepoint: Visit 2, Visit 3, Visit 4;Frequency of patients with observed worsening.Timepoint: Visit 2, Visit 3, Visit 4

Countries

India

Contacts

Public ContactDr Sharmila Patil

Bliss - Dermo cosmetic Laser Center Hair and Skin Clinic

drsharmilapatil@gmail.com918850635503

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026